NewDays is an innovative cognitive treatment designed to help people delay symptoms of cognitive decline, preserve independence, and maintain their identity. It focuses on providing access to the best tools and care for individuals living with dementia and cognitive impairment and their loved ones.

The company's mission is to empower people affected by cognitive decline to fight back and live better, longer lives as themselves through personalized therapy combined with AI-powered cognitive exercises. NewDays offers regular telehealth appointments with dedicated cognitive clinicians, personalized brain exercise homework guided by an AI companion named Sunny, and data privacy and security based on deep clinical research.

NewDays combines expert therapy with AI-powered cognitive exercises. It provides a free consultation via a 30-minute video call with a clinician, conversation-based brain exercises with new content posted daily, and a membership option with monthly subscription that includes ongoing clinician support, in-depth cognitive evaluations, and personalized treatment plans.

At the core of the treatment is Sunny, the AI brain trainer, who engages users in personal conversations to create ideal mental exercise regimens and provides timely feedback to clinicians. Sunny is trained on clinical research including the I-CONECT Study led by Dr. Hiroko Dodge of Harvard University, with NewDays holding an exclusive license to this protocol.